This website uses cookies to store user session information. By using our website you consent to our terms of use. Read more
I agree
17.09.1993
oliver.aasmets@ut.ee

Career

Institutions and positions
01.01.2021–30.09.2024   
University of Tartu, Faculty of Science and Technology, Institute of Genomics, Specialist (0,30)
01.09.2020–31.12.2020   
University of Tartu, Institute of Genomics, Specialist (0,30)
01.10.2019–31.08.2020   
University of Tartu, Institute of Genomics, Specialist (0,10)
 
 
Education
2012–30.06.2015   
University of Tartu, mathematical statistics, bachelor studies
29.10.2020
17.09.1993
oliver.aasmets@ut.ee

Teenistuskäik

Töökohad ja ametid
01.01.2021–30.09.2024   
Tartu Ülikool, Loodus- ja täppisteaduste valdkond, genoomika instituut, spetsialist (0,30)
01.09.2020–31.12.2020   
Tartu Ülikool, Tartu Ülikooli genoomika instituut, spetsialist (0,30)
01.10.2019–31.08.2020   
Tartu Ülikool, Tartu Ülikooli genoomika instituut, spetsialist (0,10)
 
 
Haridustee
2012–30.06.2015   
Tartu Ülikool, matemaatilise statistika bakalaureuseõpe
29.10.2020

Search project

  • {{item.Name}}
Institution is projects' financier   Institution is projects' executor  
  • {{searchListItem.Name}}
All   Projects   Master projects   Subprojects  
New Frascati (2015)
Old and new Frascati
All
Ongoing
Finished
Beginning
Fuzzy
Precise
  • Found 3 results
ProgramTypeNumberNameProject startProject endPrincipal investigatorInstitutionFinancing
TKSLTMR16142T (TK142)Centre of Excellence for Genomics and Translational Medicine (TK142)01.01.201601.03.2023Andres MetspaluUniversity of Tartu, Estonian Genome Center 4 474 349,50 EUR
PUT; PUT_SPPUT1371The interplay between gut microbiota and metformin treatment in type 2 diabetes through bile acid metabolism01.01.201731.10.2021Elin OrgUniversity of Tartu, Estonian Genome Center ; University of Tartu, Institute of Genomics222 244,00 EUR
1.2.1.3.2.6.MP1GI21013 (S-BMT-21-11 (LT08-2-LMT-K-01-060))Gut-blood-liver axis: Circulating microbiome as non-invasive biomarker for Inflammatory bowel disease (IBD) and Primary sclerosing cholangitis (PSC) 01.01.202131.12.2023Elin OrgUniversity of Tartu, Institute of Genomics130 000,00 EUR